About Symphony Allegro

About company

Symphony Allegro is supporting the advancement of AZ-004 through Phase III clinical trials for the treatment of acute agitation in patients with schizophrenia and bipolar disorder, AZ-104 through Phase IIa clinical trials for the treatment of migraine, and AZ-002 through Phase IIb clinical trials for the treatment of panic attack in patients with panic disorder.